Idexx Laboratories (IDXX) Change in Receivables (2009 - 2026)

Idexx Laboratories' Change in Receivables history runs 18 years deep, the most recent figure standing at $56.8 million for Q1 2026.

• In Q1 2026, Change in Receivables rose 25.57% year-over-year to $56.8 million; the TTM figure through Mar 2026 stood at $80.3 million (up 308.0% YoY), while the FY2025 annual figure was $68.7 million, up 143.01% from the prior year.
• Change in Receivables for Q1 2026 stood at $56.8 million, up from -$13.9 million in the prior quarter.
• The five-year high for Change in Receivables was $56.8 million in Q1 2026, with the low at -$27.8 million in Q4 2024.
• The 5-year median for Change in Receivables is $16.3 million (2022), against an average of $14.7 million.
• The sharpest annual moves came in 2022 and 2024: Change in Receivables surged 505.16% in 2022, then plunged 3953.5% in 2024.
• Idexx Laboratories' Change in Receivables stood at $6.3 million in 2022, then slumped by 110.83% to -$686000.0 in 2023, then slumped by 3953.5% to -$27.8 million in 2024, then jumped by 50.14% to -$13.9 million in 2025, then surged by 509.75% to $56.8 million in 2026.
• Business Quant data shows IDXX's Change in Receivables at $56.8 million in Q1 2026, -$13.9 million in Q4 2025, and $7.7 million in Q3 2025.